Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study

Table 2

Central macular thickness (CMT) measured by OCT in both groups.

	Pretreatment	3rd month	6th month	12th month
Group I	392.6 ± 33.16	332.7 ± 8.2	321.8 ± 11.2	314.7 ± 4.43
Group II	397.3 ± 14.6	340.9 ± 5.2	325.9 ± 15.6	319.6 ± 7.8
value	0.6	0.5	0.5	0.7